Proven Lung Cancer Patient Recruitment Results
Our specialized lung cancer recruitment platform delivers faster enrollment across NSCLC, SCLC, and targeted therapy trials.
Comprehensive Lung Cancer Patient Recruitment
Expert recruitment across all lung cancer types, stages, and biomarker populations for accelerated clinical trial enrollment.
Non-Small Cell Lung Cancer (NSCLC)
Specialized recruitment for adenocarcinoma, squamous cell, and large cell lung cancers
Small Cell Lung Cancer (SCLC)
Expert targeting of SCLC patients for immunotherapy and targeted therapy trials
EGFR Mutation Positive
Focused recruitment for EGFR-positive NSCLC patients requiring targeted therapies
ALK Rearrangement Positive
Specialized targeting of ALK-positive lung cancer patients for precision medicine trials
Advanced/Metastatic Lung Cancer
Stage IIIB-IV lung cancer patient recruitment for breakthrough therapy trials
Early-Stage Lung Cancer
Stage I-III lung cancer recruitment for adjuvant and neoadjuvant studies
Advanced Lung Cancer Recruitment Strategies
Multi-channel approach combining digital outreach, pulmonologist networks, and patient advocacy partnerships.
Digital Patient Outreach
Targeted campaigns reaching lung cancer patients through social media, search marketing, and patient portals
Pulmonology Network Partnerships
Direct relationships with lung cancer specialists, thoracic oncologists, and cancer centers
Patient Advocacy Collaboration
Partnerships with lung cancer foundations, support groups, and survivor communities
Biomarker Testing Coordination
EGFR, ALK, ROS1, and PD-L1 testing coordination for precision recruitment